Your browser doesn't support javascript.
loading
Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen, Hui-Jin; Wang, Chang-Guan; Dou, Hong-Liang; Feng, Xue-Feng; Xu, Yi-Min; Ma, Zhi-Zhong.
Afiliación
  • Chen HJ; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
  • Wang CG; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
  • Dou HL; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
  • Feng XF; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
  • Xu YM; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
  • Ma ZZ; Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China. puh3_yk@bjmu.edu.cn.
Ann Palliat Med ; 9(1): 82-89, 2020 Jan.
Article en En | MEDLINE | ID: mdl-32005066

Texto completo: 1 Colección: 01-internacional Asunto principal: Vitrectomía / Inhibidores de la Angiogénesis / Retinopatía Diabética / Ranibizumab Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Ann Palliat Med Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Vitrectomía / Inhibidores de la Angiogénesis / Retinopatía Diabética / Ranibizumab Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Ann Palliat Med Año: 2020 Tipo del documento: Article País de afiliación: China